Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -5.01% vs -1.64% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -62.93% vs 16.21% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -36.63% vs -9.60% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Tibet Weixinkang Medicine Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -5.01% vs -1.64% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -23.57% vs 15.89% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -62.93% vs 16.21% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -54.39% vs 4.72% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -36.63% vs -9.60% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -47.15% vs 107.61% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






